[Fundamentals and clinical significance of steroid hormone receptors, 17 beta-hydroxysteroid-dehydrogenase and serum tumor markers in endometrial carcinoma].
D015067:17-Hydroxysteroid Dehydrogenases / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D004717:Endometrium / Q000032:analysis; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D011959:Receptors, Estradiol; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D011987:Receptors, Steroid / Q000032:analysis*; D014594:Uterine Neoplasms / Q000032:analysis* / Q000473:pathology
D002272:Carcinoembryonic Antigen; D011959:Receptors, Estradiol; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D011987:Receptors, Steroid; D015067:17-Hydroxysteroid Dehydrogenases
Grundlagen und klinische Bedeutung von Steroidhormon-Rezeptoren, 17 beta-Hydroxysteroid-Dehydrogenase und Serum-Tumormarker beim Endometriumkarzinom.